Eli Lilly & Co. Acquires Alnara Pharmaceuticals for Undisclosed Sum

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a57eca47-c3b7-4541-bb6d-b9def31ab622&Preview=1
Date
7/2/2010
Company Name
Alnara Pharmaceuticals
Mailing Address
840 Memorial Drive Cambridge, MA 02139
Company Description
Alnara Pharmaceuticals Inc is a pharmaceutical company developing innovative non-systemic protein therapeutics for the treatment of metabolic and inflammatory diseases.
Website
http://www.alnara.com
Transaction Type
M&A
Transaction Amount
Undisclosed
Transaction Round
Proceeds Purposes
M&A Terms
Financial terms of the transaction were not disclosed.